Table 1. Relationship between C9orf86 expression level and clinicopathological variables of BC patients.
| Number of cases | C9orf86 expression | |||
| Varible | Low | High | P-value | |
| Age (median age) | ||||
| ≤47 | 152 | 106 | 46 | |
| >47 | 150 | 84 | 66 | 0.013 |
| AJCC clinical stage | ||||
| I+II | 235 | 145 | 90 | |
| III | 67 | 46 | 21 | 0.298 |
| Lymph node status | ||||
| No metastasis | 146 | 98 | 48 | |
| Metastasis | 156 | 93 | 63 | 0.176 |
| Recurrence | ||||
| No | 247 | 159 | 88 | |
| Yes | 55 | 32 | 23 | 0.389 |
| Tumor size | ||||
| ≤2.0 cm | 78 | 56 | 22 | |
| > 2.0, ≤5.0 cm | 185 | 110 | 75 | |
| >5 cm | 23 | 18 | 4 | 0.034 |
Abbreviations: BC, breast cancer; AJCC, American Joint Committee on Cancer.